These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 30699493
1. [Drug-induced osteonecrosis of the jaw - not just bisphosphonates]. Finkelshteyn A, Yarom N. Refuat Hapeh Vehashinayim (1993); 2017 Jan; 34(1):32-35, 72. PubMed ID: 30699493 [Abstract] [Full Text] [Related]
2. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I. Turner B, Drudge-Coates L, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P. Urol Nurs; 2016 Jan; 36(3):111-6, 154. PubMed ID: 27501591 [Abstract] [Full Text] [Related]
3. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer. Van Poznak C. Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002 [Abstract] [Full Text] [Related]
4. Denosumab, an Alternative to Bisphosphonates but also Associated with Osteonecrosis of the Jaw--What is the Risk? Sidhu HK. Dent Update; 2015 Jun; 42(5):436-8, 440. PubMed ID: 26964445 [Abstract] [Full Text] [Related]
5. Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. Loyson T, Van Cann T, Schöffski P, Clement PM, Bechter O, Spriet I, Coropciuc R, Politis C, Vandeweyer RO, Schoenaers J, Dumez H, Berteloot P, Neven P, Nackaerts K, Woei-A-Jin FJSH, Punie K, Wildiers H, Beuselinck B. Acta Clin Belg; 2018 Apr; 73(2):100-109. PubMed ID: 28693379 [Abstract] [Full Text] [Related]
6. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB. Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [Abstract] [Full Text] [Related]
7. [Osteonecrosis of the jaw]. Drozdzowska B. Endokrynol Pol; 2011 Nov; 62 Suppl 3():4-9. PubMed ID: 22161980 [Abstract] [Full Text] [Related]
8. Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients. Owosho AA, Blanchard A, Levi L, Kadempour A, Rosenberg H, Yom SK, Farooki A, Fornier M, Huryn JM, Estilo CL. J Craniomaxillofac Surg; 2016 Mar; 44(3):265-70. PubMed ID: 26782845 [Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution. La Verde N, Bareggi C, Garassino M, Borgonovo K, Sburlati P, Pedretti D, Bianchi C, Perrone S, Mihali D, Cobelli S, Mantica C, Rizzo A, Farina G. Support Care Cancer; 2008 Nov; 16(11):1311-5. PubMed ID: 18663482 [Abstract] [Full Text] [Related]
10. Review of current literature and implications of RANKL inhibitors for oral health care providers. Epstein MS, Ephros HD, Epstein JB. Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Dec; 116(6):e437-42. PubMed ID: 22901640 [Abstract] [Full Text] [Related]
11. Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Dabagh RA, Davison KS, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, International Task Force on Osteonecrosis of the Jaw. J Clin Densitom; 2017 Dec; 20(1):8-24. PubMed ID: 27956123 [Abstract] [Full Text] [Related]
12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538 [Abstract] [Full Text] [Related]
13. Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. Van Poznak C, Estilo C. Oncology (Williston Park); 2006 Aug; 20(9):1053-62; discussion 1065-6. PubMed ID: 16986349 [Abstract] [Full Text] [Related]
14. Antiresorptive drug-related osteonecrosis of the jaw. Uyanne J, Calhoun CC, Le AD. Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528 [Abstract] [Full Text] [Related]
15. Retrospective Audit: Does Prior Assessment by Oral and Maxillofacial Surgeons Reduce the Risk of Osteonecrosis of The Jaw in Patients Receiving Bone-Targeted Therapies for Metastatic Cancers to the Skeleton?--Part II. Turner B, Ali S, Pati J, Nargund V, Ali E, Cheng L, Wells P. Urol Nurs; 2016 Apr; 36(3):117-22, 132. PubMed ID: 27501592 [Abstract] [Full Text] [Related]
17. Effect of antiresorptive drugs on bony turnover in the jaw: denosumab compared with bisphosphonates. Ristow O, Gerngroß C, Schwaiger M, Hohlweg-Majert B, Kehl V, Jansen H, Hahnefeld L, Koerdt S, Otto S, Pautke C. Br J Oral Maxillofac Surg; 2014 Apr; 52(4):308-13. PubMed ID: 24582013 [Abstract] [Full Text] [Related]
18. Antiresorptive treatment-associated ONJ. Eleutherakis-Papaiakovou E, Bamias A. Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 29063702 [Abstract] [Full Text] [Related]
19. [Possible denosumab-induced jaw osteonecrosis in the treatment of osteoporosis. A case report]. Selvi Sabater P, Rizo Cerdá AM, Titos Arcos JC, Espuny Miró A. Farm Hosp; 2014 May 01; 38(3):248-9. PubMed ID: 24951910 [Abstract] [Full Text] [Related]
20. Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series. Landesberg R, Wilson T, Grbic JT. Dent Today; 2006 Aug 01; 25(8):52, 54-7. PubMed ID: 16925161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]